HeartSciences Inc.
HSCS
$3.46
$0.113.28%
NASDAQ
| 01/31/2025 | 10/31/2024 | 07/31/2024 | 04/30/2024 | 01/31/2024 | |
|---|---|---|---|---|---|
| Revenue | -- | -- | -- | -- | 635.00% |
| Total Other Revenue | -- | -- | -- | -- | -- |
| Total Revenue | -- | -- | -- | -- | 635.00% |
| Cost of Revenue | -- | -- | -- | -- | 475.00% |
| Gross Profit | -- | -- | -- | -- | 741.67% |
| SG&A Expenses | 30.45% | -3.55% | 11.20% | -21.66% | 53.78% |
| Depreciation & Amortization | -- | -- | -- | -- | -- |
| Other Operating Expenses | -- | -- | -- | -- | -- |
| Total Operating Expenses | 53.98% | 26.13% | 55.99% | 17.58% | 17.45% |
| Operating Income | -55.47% | -26.44% | -55.99% | -17.58% | -16.51% |
| Income Before Tax | -54.29% | -19.13% | -50.10% | -13.10% | -22.48% |
| Income Tax Expenses | -- | -- | -- | -- | -- |
| Earnings from Continuing Operations | -54.29% | -19.13% | -50.10% | -13.10% | -22.48% |
| Earnings from Discontinued Operations | -- | -- | -- | -- | -- |
| Extraordinary Item & Accounting Change | -- | -- | -- | -- | -- |
| Minority Interest in Earnings | -- | -- | -- | -- | -- |
| Net Income | -54.29% | -19.13% | -50.10% | -13.10% | -22.48% |
| EBIT | -55.47% | -26.44% | -55.99% | -17.58% | -16.51% |
| EBITDA | -55.45% | -26.28% | -55.96% | -17.51% | -16.84% |
| EPS Basic | 14.46% | 85.74% | 80.06% | 83.25% | 81.54% |
| Normalized Basic EPS | 14.46% | 85.74% | 80.06% | 83.25% | 81.54% |
| EPS Diluted | 14.46% | 85.74% | 80.06% | 83.25% | 81.54% |
| Normalized Diluted EPS | 14.46% | 85.74% | 80.06% | 83.25% | 81.54% |
| Average Basic Shares Outstanding | 80.37% | 735.52% | 652.86% | 575.03% | 563.47% |
| Average Diluted Shares Outstanding | 80.37% | 735.52% | 652.86% | 575.03% | 563.47% |
| Dividend Per Share | -- | -- | -- | -- | -- |
| Payout Ratio | -- | -- | -- | -- | -- |